Wolverine Asset Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Wolverine Asset Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.68K	Hold	147,101	–	–	﹤0.01%	1533
2025 Q4	$2.72K	Hold	147,101	–	–	﹤0.01%	1522
2025 Q3	$3.71K	Hold	147,101	–	–	﹤0.01%	1452
2025 Q2	$2.99K	Hold	147,101	–	–	﹤0.01%	1458
2025 Q1	$2.49K	Hold	147,101	–	–	﹤0.01%	1418
2024 Q4	$2.12K	Hold	147,101	–	–	﹤0.01%	1478
2024 Q3	$1.85K	Hold	147,101	–	–	﹤0.01%	1482
2024 Q2	$1.54K	Buy	147,101 +12,184	+9%	+$677	﹤0.01%	1511
2024 Q1	$9.44K	Buy	+134,917	New	+$8.4K	﹤0.01%	1305

Other funds holding PBMWW

Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return